Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elements
(Q37505185)
scientific article published on 12 January 2012
scientific article published on 12 January 2012
Language:
Current Data About
Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elements
other details
| description | scientific article published on 12 January 2012 |
External Links
| (P356) |
10.1158/1078-0432.CCR-11-0563
|
| (P698) |
22241789
|
| (P932) |
5157199
|
| (P8608) |
release_lx6ajhbggrdgtdudaubptfgnme
|